Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin pharmacokinetics during adult cardiac surgery after new prophylaxis protocol implementation
NL-OMON48705Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2019
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cefazolin in surgical site infection (SSI), sponsored by Erasmus MC. Primary endpoint: Time and concentration of cefazolin above MIC. Started Mar 2019; status: active, not recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NL-OMON48705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48705.